KRAS and pachyonychia congenita: MiR-21 has been demonstrated to be overexpressed in early PC and PC-derived cell lines, which are generally considered downstream of the carcinogenic pathway, regulating targeted genes through pathways such as KRAS (Du Rieu et al., 2010; Moriyama et al., 2009).